Perpetual Medicines Raises $8M in Seed Funding

Perpetual Medicine, a Shanghai, China- and Boston, MA-based computational peptide therapeutics company, raised $8M in Seed funding.

The round was led by Chengwei Capital.

The company intends to use the funds to advance its integrated computational design and synthesis platform for peptide drug discovery.